Skip to Content

UW-Madison virologists and vaccine companies collaborating on COVID-19 vaccine

Remaining Ad Time Ad - 00:00

MADISON (WKOW) -- A collaboration between virologists at the University of Wisconsin-Madison and vaccine companies FluGen and Bharat Biotech has begun developing and testing a unique vaccine against COVID-19 called CoroFlu.

Refinement of the CoroFlu vaccine concept and testing in laboratory animal models at UW-Madison is expected to take three to six months.

FluGen is based in Madison.

Bharat Biotech in Hyderabad, India will then begin production scale-up for safety and efficacy testing in humans.

CoroFlu could be in human clinical trials by the fall of 2020.

For full details of the report click here.

Matthew Cash

Senior Executive Producer

Skip to content